Q32 Bio Stock (NASDAQ:QTTB), Quotes and News Summary

Q: What sector and industry does Q32 Bio (QTTB) operate in?

Q32 Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Q32 Bio Stock (NASDAQ: QTTB) stock price, news, charts, stock research, profile.

Open	$31.000
Close	-
Volume / Avg.	18.770K / 41.412K
Day Range	29.595 - 32.214
52 Wk Range	15.070 - 32.880
Market Cap	$370.027M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	-
Days to Cover	1

Recent News

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.6

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Q32 Bio (QTTB) stock?

You can purchase shares of Q32 Bio (NASDAQ: QTTB) through any online brokerage.

View our list of the best stock brokerages.

Who are Q32 Bio's (QTTB) competitors?

Other companies in Q32 Bio’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Replimune Group (NASDAQ:REPL), Inovio Pharmaceuticals (NASDAQ:INO) and Anika Therapeutics (NASDAQ:ANIK).

What is the target price for Q32 Bio (QTTB) stock?

The latest price target for Q32 Bio (NASDAQ: QTTB) was reported by Oppenheimer on Thursday, April 11, 2024. The analyst firm set a price target for 50.00 expecting QTTB to rise to within 12 months (a possible 61.29% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Q32 Bio (QTTB)?

The stock price for Q32 Bio (NASDAQ: QTTB) is $31 last updated May 16, 2024 at 4:03 PM EDT.

Does Q32 Bio (QTTB) pay a dividend?

There are no upcoming dividends for Q32 Bio.

When is Q32 Bio (NASDAQ:QTTB) reporting earnings?

Q32 Bio’s Q2 earnings are confirmed for Saturday, August 3, 2024.

Is Q32 Bio (QTTB) going to split?

There is no upcoming split for Q32 Bio.

What sector and industry does Q32 Bio (QTTB) operate in?

Q32 Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-